Sign in

Trial result ·

Safety, pharmacokinetics, and preliminary efficacy of hetrombopag in pediatric patients with aplastic anemia: A pilot study.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study tested a drug called hetrombopag in children with aplastic anemia. None of the children could have a stem cell transplant. They took hetrombopag along with drugs that calm the immune system. The team looked at safety and at drug levels in the blood. They also checked blood count responses at 3 and 6 months. This was a pilot study, which is an early first test.

What they found

In all, 21 children took part. They were aged 1-5, 6-11 or 12-17 years. Of them, 18 had severe disease and 3 had non-severe disease. The most common side effects were raised liver enzymes and raised bilirubin. Drug levels in the blood changed with age. Children aged 6-11 varied the most and had too much drug in the blood. Among the 18 with severe disease, 10 had a blood response at 3 months. Only 1 child had a full response at that time. By 6 months, 13 had a response and 4 had a full response.

What it means for patients

The authors say the drug plus immune drugs seemed safe in these children. They say it showed early signs that it may work. They found that drug levels in the blood depend on age. They say more studies should look at doses set for each child.

Why it is not certain yet

Only 21 children were in the study. The abstract reports results up to 6 months only. The abstract does not describe a comparison group. All children also got immune drugs, so the effect of each drug is mixed. Doses may need to change for some ages, and this is not yet known.

Source

Safety, pharmacokinetics, and preliminary efficacy of hetrombopag in pediatric patients with aplastic anemia: A pilot study.

PubMed · PMID 42315650

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Aplastic anaemia publications